Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Furio Pacini

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
European Journal of Endocrinology|November 13, 2004
Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practiceMartin Schlumberger, Furio Pacini, Wilmar M Wiersinga, et al.
The Journal of Clinical Endocrinology and Metabolism|February 17, 2010
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this questionRossella Elisei, Eleonora Molinaro, Laura Agate, et al.
European Journal of Endocrinology|April 16, 2010
Acute exogenous TSH administration stimulates leptin secretion in vivoFerruccio Santini, Giulia Galli, Margherita Maffei, et al.
Healthcare (Basel, Switzerland)|September 23, 2022
Tackling Thyroid Cancer in Europe-The Challenges and OpportunitiesDenis Horgan, Dagmar Führer-Sakel, Paula Soares, et al.
Thyroid : Official Journal of the American Thyroid Association|August 23, 2013
Ernest L. Mazzaferri, MD, MACP (1936-2013)Richard T Kloos, Jennifer A Sipos, Manuel Tzagournis, et al.
The Journal of Clinical Endocrinology and Metabolism|April 24, 2008
Thyroid autoantibodies and thyroid function in subjects exposed to Chernobyl fallout during childhood: evidence for a transient radiation-induced elevation of serum thyroid antibodies without an increase in thyroid autoimmune diseaseLaura Agate, Stefano Mariotti, Rossella Elisei, et al.
The Lancet. Oncology|October 11, 2018
Long-term strategies for thyroid health monitoring after nuclear accidents: recommendations from an Expert Group convened by IARCKayo Togawa, Hyeong Sik Ahn, Anssi Auvinen, et al.
The Journal of Clinical Endocrinology and Metabolism|May 6, 2004
BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomasEfisio Puxeddu, Sonia Moretti, Rossella Elisei, et al.
International Journal of Cancer|January 25, 2002
Establishment of a non-tumorigenic papillary thyroid cell line (FB-2) carrying the RET/PTC1 rearrangementFulvio Basolo, Riccardo Giannini, Antonio Toniolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2009
Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancerMartin J Schlumberger, Rossella Elisei, Lars Bastholt, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
European Journal of Endocrinology|November 13, 2004
Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practiceMartin Schlumberger, Furio Pacini, Wilmar M Wiersinga, et al.
The Journal of Clinical Endocrinology and Metabolism|February 17, 2010
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this questionRossella Elisei, Eleonora Molinaro, Laura Agate, et al.
European Journal of Endocrinology|April 16, 2010
Acute exogenous TSH administration stimulates leptin secretion in vivoFerruccio Santini, Giulia Galli, Margherita Maffei, et al.
Healthcare (Basel, Switzerland)|September 23, 2022
Tackling Thyroid Cancer in Europe-The Challenges and OpportunitiesDenis Horgan, Dagmar Führer-Sakel, Paula Soares, et al.
Thyroid : Official Journal of the American Thyroid Association|August 23, 2013
Ernest L. Mazzaferri, MD, MACP (1936-2013)Richard T Kloos, Jennifer A Sipos, Manuel Tzagournis, et al.
The Journal of Clinical Endocrinology and Metabolism|April 24, 2008
Thyroid autoantibodies and thyroid function in subjects exposed to Chernobyl fallout during childhood: evidence for a transient radiation-induced elevation of serum thyroid antibodies without an increase in thyroid autoimmune diseaseLaura Agate, Stefano Mariotti, Rossella Elisei, et al.
The Lancet. Oncology|October 11, 2018
Long-term strategies for thyroid health monitoring after nuclear accidents: recommendations from an Expert Group convened by IARCKayo Togawa, Hyeong Sik Ahn, Anssi Auvinen, et al.
The Journal of Clinical Endocrinology and Metabolism|May 6, 2004
BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomasEfisio Puxeddu, Sonia Moretti, Rossella Elisei, et al.
International Journal of Cancer|January 25, 2002
Establishment of a non-tumorigenic papillary thyroid cell line (FB-2) carrying the RET/PTC1 rearrangementFulvio Basolo, Riccardo Giannini, Antonio Toniolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2009
Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancerMartin J Schlumberger, Rossella Elisei, Lars Bastholt, et al.
Pageof 15